HRT Financial’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

HRT Financial’s Portfolio BIS Stock Details BIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,995	Closed	-$928K	–	1860
2020 Q3	$928K	Buy	14,995 +11,577	+339%	+$740K	0.03%	595
2020 Q2	$219K	Sell	3,418 -3,538	-51%	-$275K	0.01%	1119
2020 Q1	$787K	Buy	6,956 +3,213	+86%	+$367K	0.05%	302
2019 Q4	$401K	Buy	3,743 +439	+13%	+$56.5K	0.02%	620
2019 Q3	$529K	Buy	3,304 +1,758	+114%	+$258K	0.03%	650
2019 Q2	$210K	Sell	1,546 -164	-10%	-$24K	0.01%	621
2019 Q1	$228K	Buy	+1,710	New	+$242K	0.04%	356
2018 Q3	–	Sell	-1,418	Closed	-$220K	–	410
2018 Q2	$220K	Buy	+1,418	New	+$236K	0.08%	192
2017 Q1	–	Sell	-1,469	Closed	-$411K	–	126
2016 Q4	$411K	Buy	+1,469	New	+$402K	0.52%	30

Other funds holding BIS

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HRT Financial's BIS Position: Q4 2020 in Review

HRT Financial sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q4 2020, closing a stake of 14,995 shares — an estimated $928K sold.

HRT Financial first reported a position in BIS in Q4 2016 and held it in 9 quarters. The position peaked at $928K in Q3 2020. 9 funds tracked by Wall St. Rank hold BIS as of Q4 2020.

HRT Financial reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q4 2020 after selling out during the quarter.
HRT Financial sold 14,995 ProShares UltraShort NASDAQ Biotechnology shares in Q4 2020, an estimated $928K.
HRT Financial first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q4 2016 and held it in 9 quarters.
HRT Financial's ProShares UltraShort NASDAQ Biotechnology position peaked at $928K in Q3 2020.
9 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q4 2020.

Based on HRT Financial's 13F filing for Q4 2020, filed 16 Feb 2021.